genetic | 
12 3rd, 2007| 
A new wave of automated, inexpensive, and high-throughput multiplexing technologies has been widely reported on of late. Diagnostic laboratories and clinical pharmacologists will find these multiplexing systems ideal for identifying and validating biomarkers for diverse applications ranging from testing for adverse drug reactions (ADR) to prognostics and diagnostics. Read the rest of this entry »